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ABSTRACT 
Objective: The research work unveils the use of nuclear magnetic resonance (NMR) technique for quantitative determination and method 
validation of obeticholic acid. As standard expository methodology for more up to date medications or formulations may not be available in 
pharmacopeias, hence it is fundamental need to create novel analytical procedures which should be precise and accurate.  
Methods: Proton (1H) and carbon (13C) NMR analysis were initially performed to confirm the preliminary authenticity of obeticholic acid API. 
Method validation was accomplished on the basis of standard guidelines for the parameters, in which tetramethylbenzene as an internal standard 
and deuterated dimethyl sulfoxide as a diluent were used to assess the obeticholic acid.  
Results: For the quantification of the drug, the proton nuclear magnetic resonance signals at 0.602 ppm and 6.86 ppm corresponding to the analyte 
proton of drug and internal standard respectively were used. The curve equation calculated from the regression method, the relative-standard-
deviation and correlation-coefficient were found to be 0.743% and 0.9989 respectively, indicating good linearity. Consequently, the quantitative 
assay of the drug was found to be 99.91% in linearity with limit of detection and quantification values as 0.0773 mg and 0.2344 mg respectively, 
making successful the study of method validation for obeticholic acid.  
Conclusion: The advantage of the method was that no reference standard of analyte drug was required for quantification and method validation. 
The method is non-destructive and can be applied for quantification of drug in commercial pharmaceutical formulation products. 
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INTRODUCTION 
NMR spectroscopy is a well-accepted analytical technique for 
structure elucidation of simple as well complex molecules and 
engaged in many branches of biochemistry [1, 2]. It has been 
deliberated as a rapid, precise, reliable, non-destructive and 
convenient method for quantitative estimation and is a strategic 
analytical tool for the unidentified synthetic as well as natural 
compounds [3, 4]. As, it has demonstrated the distinguishing 
benefits of providing instantaneous access to both quantitative as 
well qualitative evaluation; later on is demarcated by prime ratio 
rule in that the intensity (signal) is straightly equivalent to the nuclei 
number which engender due to a specific resonant [5, 6]. 
Obeticholic acid (C26H44O4) is a semi-synthetic chenodeoxycholic 
acid (CDCA) derivative and is also known by various terms or names 
such as OCA, 6-ethyl-CDCA, INT-747 and 6α-ethyl-3α,7α-dihydroxy-
5-cholan-24-oic acid (fig. 1). In 2002, Pellicciari et al. [7] reported 
this semi-synthetic ligand, has agonistic action for farnesoid-X 
reeptor (FXR) [8]. A major revolution toward the synthetic bile acid 
compounds was the finding of this potent and selective FXR agonist 
obeticholic acid which has 100 ~fold greater activity than natural 
agonist [8, 9]. It is an approved drug by the federal regulatory 
agencies (US FDA) in 2016 for the treatment of primary-biliary-
cholangitis (PBC) patients who have insufficient response to UDCA, 
and also it is on phase III and II trial for treatment of nonalcoholic 
steato-hepatitis (NASH) and PSC (ClinicalTrials. gov, number 
NCT01265498 and NCT02177136) [10, 11]. A numerous analytical 
method has been reported over time for the determination of 
obeticholic acid in biological fluids or individually in which mainly 
includes chromatographic-based HPLC/lC-MS [12-14] and other 
analysis like volumetric with visual end-point detection [15].  
Although, the proposed method is relatively fast, simple, precise, 
selective and sensitive sufficient for all observed related compounds 
of obeticholic acid compared with previously published studies 
mainly had used HPLC-MS [12-14] to define the concentration of 
obeticholic acid in plasma, and its methods were not explained 
whatsoever because they didn’t perform comprehensive method 
validation, detailed method optimization as per international council 
for harmonisation (ICH) parameters like Malz et al., El-Sheikh et al. 
and Harahap et al. performed [16-18]. Thus, the research has been 
undertaken and this paper reflect the work of developing 
advantageous and competitive selective NMR method for the 
determination of the drug in formulation as well as in active 
pharmaceutical ingredient (API) samples that complies well with the 
validation requirements in the pharmaceutical industry as per 















Fig. 1: Molecular structure of obeticholic acid 
 
MATERIALS AND METHODS 
Chemicals and standards 
Analytically graded pure substances were utilized all through 
the work. Authentic sample of obeticholic acid API was got from 
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local Mankind Pharma, Gurugram, as gift sample and used as a 
standard as such. Tetramethylbenzene (TMB) (98%) (lot 
#MKBQ2241V) purchased from Sigma Aldrich chemicals was 
used as internal standard, deuterated dimethyl sulfoxide (DMSO-
d6) (99.99%) (lot #MKBR3576V) and deuterium oxide (D2O) 
(99.99%) (lot #S2BC1895V) purchased from Sigma Aldrich 
chemicals were utilized as a solvent. Obetix 5 tablets (Marketed 
drug) containing 5 mg obeticholic acid were bought from the 
local supplier (Manufactured: Beacon Pharmaceuticals Limited, 
Bangladesh). 
Instrumentations 
NMR experiments were performed on Bruker Avance-III HD 400 
MHz and Avance-II 400 MHz ultra-shield spectrometer 
(JCL/ANAL/NMR/02 and 03) equipped with a 5 mm multinuclear 
broad-band-observe (BBO) probe-head and 5 mm 1H-13C dual probe-
head respectively. Other instruments were also used for drug 
characterization, sample preparations and comparison of assay 
result that are FT-IR instrument: Perkin Spectrum Two FT-IR 
114570 spectrometer (GCD FIR 02 2020), LC-MS: ultra-high-
performance liquid chromatography-mass spectrometry (ID: 
UHPLC-MS-01) equipped with a dual agilent jet stream electrospray 
ionization (AJS-ESI) and evaporative light scattering detector (ELS1 
A), Melting point: Buchi Melting Point (QCD/MPT-01), weighing 
machine: mettler Toledo XS 205 dual range 
(JCL/ANAL/BALANCE/03) and Sonicator: Ultrasonicator 
(JCL/ANAL/US/01). 
Procedural condition for protonnuclear magnetic resonance 
spectroscopy method 
The NMR experiments were concluded for standard preparation in 
the six replicate (n=6) preparation, under the acquisition 
parameters or experimental circumstances for the quantitative 
analysis which were as: 32 scans, 90 ° pulse (pulse-program: zg), 
acquisition time (aq) of 1.99 seconds, relaxation delay (d1) 10.00 
seconds, a spectrum width (swh) of 10416.66 Hz, exponential line-
broadening function (lb) = 0.3Hz were applied for all spectra 
erstwhile with manual baseline and phasing adjustment, and 
integrated areas were fixed within 20 times width of the signal on 
half-height. All acquired data were processed via TopSpin 3.2 
(Bruker) software. 
Procedure for liquid chromatography-mass spectrometry 
For this experiment, 1 mg of obeticholic acid was accurately weighed 
and transferred to a 10 ml volumetric flask and then introduced 10μl 
in the mobile phase stream. 
Preparation of standard and test solutions 
Stock solution of internal standard  
Accurately weighed 666.66 mg of TMB (10.00 mg/0.6 ml) was 
transferred into volumetric flask in which added DMSO-d6 solvent 
and volume made upto 40 ml with the same solvent and mixed-well 
by sonicating the flask. 
Standard preparation for specificity 
8.11 mg obeticholic acid standard was balanced accurately, 
transferred into NMR tube in which 0.6 ml of DMSO-d6 was added. 
This solution was well-mixed until completely dissolved.  
Internal standard preparation for specificity 
Accurate 0.6 ml of previously prepared stock solution of TMB 
internal standard was utilized directly. 
Sample preparation 
Five tablets of Obetix 5 were weighed, crushed and triturated 
thoroughly into fine powder. Portion equivalent to 10 mg obeticholic 
acid drug was weighed accurately and transferred to NMR tube. 
Then 0.6 ml of stock solution of TMB internal standard was added. 
Solution was thoroughly mixed well and sonicated but due to lots of 
excipient it was not complete dissolved and even solvent lock 
problem appeared during acquisition.  
Calculation 
The percentage purity (Px) of drug and their actual amount can be 










Pstd ……. (1) 
Where, Px = percentage purity of the analyte (obeticholic acid) drug 
(%w/w), Ix = Integral mean value of the obtained analyte proton 
signal, Istandard = Integral mean value of the obtained proton signal of 
internal standard, Nstandard = Number of internal standard protons, Nx 
= Number of analyte drug protons, Mx = Molar mass of the 
obeticholic acid, Mstandard = Molar mass of the internal standard, 
mstandard = Weight of the internal standard (mg), mx = Taken amount 
of the analyte drug (mg), Pstandard = Known purity of the internal 
standard. 
Quantitative method validation  
The relevant analytical methods validation has turn into a crucial 
part in drug characterization and development. Method validation 
involves experimental strategy to demonstrate that the method 
could yield accurate and precise results within the limit of its 
envisioned use [21]. However, the method is based on the provisions 
established in ICH guideline Q2(R1). The parameters of validation 
includes specificity, selectivity, precision, linearity, LOD, LOQ, 
accuracy, and robustness were studied. 
Selectivity and specificity 
Specificity and selectivity is a practice denotes to the way of 
performing the identification and evaluation of signals such as 
interference by other peaks, overlapping etc. to ensure the desired 
signal for quantification purpose is well separated and has good 
intensity. This can be done by several experiments like 2D 
dimensional experiments such as 1H-1H COSY and 1H-13C HMQC may 
employ to verify whether the signals of the internal standard and 
analyte proton is proper isolated by individually in test and standard 
sample preparations [19]. 
Linearity 
The percentage ranging amount from 70% to 120% of obeticholic 
acid was covered to plot a linearity curve using the regression/least-
squares method. It was performed by preparing six different 
concentrated standard solutions and this analysis of statistics 
recommended by Junqueira and De-Souza [22] was engaged for 
linearity evaluation. The method evidences for homoscedasticity, 
normality and individuality of residuals were statistically proven 
after taking out.  
Precision and intermediate precision 
In analytical method the precision stated as proximity of a 
settlement between sequences of evaluation acquired from 
numerous sampling of the identical consistent sample. It is depends 
on the integration procedure of quantitative NMR such as the S/N 
share of the concern signals. S/N share necessary minimal 150:1 for 
each resonant line that must be assimilated for a precision superior 
than 99% or a variability of 1% [16]. The ICH guidelines stated that 
precision shall be obtained by six repetitive evaluations (n=6) and 
intermediate precision shall be analyzed by an altered analyzer on 
altered day and or altered NMR probe and or an altered NMR 
spectrometer with an altered strength of magnetic-field. 
Accuracy  
In analytical method the accuracy denoted that the proximity of 
agreement between a recognized standard value and the found 
value. The ICH guidelines stated that the accuracy must be evaluated 
by utilizing a minimal nine preparations concludes at least three 
concentration levels, to cover the stated spectrum (for example: 3 
concentrations and 3 multiples of every concentration) [19]. 
LOD and LOQ  
The LOD and LOQ are obtained by employing the curve factors 
acquired in the linearity. The proportion between the standard 
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deviation (SD) and the coefficient of angular was multiply with 3.3 to 
get the LOD and multiply with 10 to get the LOQ [23]. 
Robustness  
The robustness of an analytical method is evaluated by via Plackett-
Burman strategy for eleven factors. The examined features are 
parameters which can probably influence on quantification, among 
those the frequently selected parameters are the number of scans 
and dummy-scans, pulse angle, relaxation delay, number of data 
points, pulse calibration and zero-filling as discussed in the 
literature [16, 20]. 
RESULTS AND DISCUSSION 
As standard expository methodology for more up to date 
medications or formulations may not be available in pharmacopeias, 
hence it is fundamental need to create novel analytical procedures 
which should be precise and accurate. The proposed method is 
relatively fast, simple, precise, selective and sensitive sufficient for 
all observed related compounds of obeticholic acid compared with 
previously published studies mainly had used HPLC-MS [12-14] to 
define the concentration of obeticholic acid in plasma, and its 
methods were not explained whatsoever because they cannot 
perform broad method validation, detailed method optimization as 
according to ICH parameters. The main advantage of this proposed 
method was that no reference standard of drug was required for 
quantification and method validation, this high simplicity, reliability, 
simultaneously measurement enable it to apply for quantitation of 
obeticholic acid in future as well as existing commercial products. 
Nuclear magnetic resonance experiments for confirmation of 
structure characterization 
Structure of the analyte drug and the internal standard shown in fig. 2, 
a various experiments such as 13C NMR, APT, 1H-1H COSY and 1H-13C 
HMQC were performed in DMSO-d6 for the structural characterization 
of obeticholic acid drug. From these experiments it was noted that 
there are three hydroxyl (OH) protons are present in molecule which 
was further ensured by performing D2O exchange/shake analysis in 
which all exchangeable protons disappeared. These assessments help 
in accurate and precise assignment of all protons and carbon of 
Obeticholic acid, as resultant number of proton and carbon were found 
to be as 44 and 26 respectively (fig. 3 and 4), justifying the preliminary 
identification and confirmation of drug API. The 1H NMR analysis of 
internal standard TMB was also done in DMSO-d6 solvent for 









































(A) (B)  
Fig. 2: Chemical structure of (A) obeticholic acid and, (B) tetramethylbenzene internal standard with proton signal assigned 
 
 
Fig. 3: Proton spectra of obeticholic acid in deuterated dimethyl sulfoxide (DMSO-d6) solvent. 1H NMR interpretation (DMSO-d6, 400 MHz): 
δ= 0.602 (S, 3H, Methyl), 3.125 (S, 1H, CYHA), 3.493 (S, 1H, CYHA), 4.033 (D, 1H, J= 4.8 Hz,-OH {due to coupling with attached–CH}), 4.2873 
(D, 1H, J= 3.88 Hz,-OH {due to coupling with attached–CH}) (11.94 (S, 1H,-OH), 0.803-2.224 (clubbed peaks due to CYHA: cyclohexane) 
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Fig. 4: Carbon (13C) spectra of obeticholic acid in deuterated dimethyl sulfoxide solvent. 13C NMR interpretation (DMSO-d6, 100 MHz): 12.8 
(CH3, C-19), 23.101 (CH2, C-15), 27.848 (CH2, C-16), 30.756 (CH2, C-2 and CH2, C-22 {merged}), 32.642 (CH2, C-23), 33.555 (C, C-10), 34.953 
(CH, C-5), 35.21 (CH, C-20 and CH2, C-4 {merged}), 35.538 (CH2, C-1), 41.278 (CH2, C-12), 42.026 (C, C-13), 45.336 (CH, C-9), 50.103 (CH, C-
14), 55.539 (C, C-17), 68.402 (CH, C-3), 70.608 (CH, C-7), 174.903 (C, C-24 carboxylic acid), 38.893-39.935 (remaining carbon’s signal 
peaks are clubbed with solvent signal that is at 39.52) 
 
Assignment of proton signals of the drug and internal standard 
The 1H NMR spectra for obeticholic acid in DMSO-d6 shows in fig. 3 
in which the sharp singlet was observed at 0.602 ppm (singlet, 3H) 
due to methyl group assigned as ‘a’ of carbon (C-19). The two well 
separated and doublet signals appeared at 4.03 ppm (1H) and 4.28 
ppm (1H) (due to coupling with attached–CH) were assigned as ‘b 
and c’ respectively. These attached of cyclic aliphatic carbon (–CH) 
were confirms via 13C NMR as well in attached proton test (APT) 
NMR by observing signal at 70.59 and 68.39 ppm (C-3 and C-7). One 
well isolated carboxylic hydroxy group (–OH) signal appeared at 
11.94 ppm was assigned as‘d’. The other signals of obeticholic acid 
drug are not well separated due to cholesterol moiety and appeared 
as clubbed signals in between 0.803-2.224 ppm. Apart from 
obeticholic acid signals, residual peak and moisture of the solvent 
(DMSO-d6) were also obtained at 2.50 ppm and 3.33 ppm 




Fig. 5: Proton nuclear magnetic resonance spectra of obeticholic acid in dimethyl sulfoxide solvent, and deuterium-oxide shake which 
disappeared all exchangeable protons (like Hydroxy group) signal and appeared only singlet peak at 3.9 ppm due to moisture or 
deuterium hydroxide. 1H: proton; D2O: deuterium oxide; DMSO-d6: deuterated dimethyl sulfoxide 
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All assigned protons were also checked in D2O exchange/shake analysis 
in which test solution contents drug in 0.6 ml DMSO-d6 with 2 to 3 drops 
of D2O solvent. There were observed that all–OH protons signals at 4.03, 
4.28 ppm and 11.94 ppm disappeared or exchanged due to D2O solvent. 
So, there was only single sharp singlet observed at 3.9 ppm which is due 
to deuterium hydroxide (HOD) or moisture as shown in fig. 5. 
 
 
Fig. 6: Attached proton test (APT) spectrum of obeticholic acid in deuterated dimethyl sulfoxide (DMSO) solvent to which the peak at 
11.69 confirmed that it has odd number of protons 
 
 
Fig. 7: Proton nuclear magnetic resonance spectrum of tetramethylbenzene internal standard in deuterated dimethyl sulfoxide solvent. 
1H NMR interpretation (DMSO, 400 MHz): δ in ppm = 2.1217 (S, 3H, Methyl), 6.8682 (S, 1H, Benzene) 
 
The isolated, sharp singlet signal ‘a’ in 1H NMR followed by 13C 
NMR and APT (fig. 6) signal at 11.695 ppm of drug indicates and 
confirms the presence of odd number of protons due to methyl 
group (C-19) was selected for the purpose of quantification of 
the drug. The well isolated, sharp singlet signal at 6.86 ppm (2H) 
was due to two-CH group of TMB internal standard assigned as 
‘e’ was taken as reference signal for quantitative determination 
(fig. 7).  
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Fig. 8: Correlated and heteronuclear multiple quantum coherence spectra of obeticholic acid in deuterated dimethyl sulfoxide solvent. 1H-
1H: proton-proton; 1H-13C: proton-carbon; COSY: correlated spectroscopy; HMQC: heteronuclear multiple quantum coherence; DMSO: 
deuterated dimethyl sulfoxide 
 
Additionally, all assigned protons of drug molecule had been further 
confirmed through higher experiments such as 1H-1H correlated 
spectroscopy (COSY) and 1H-13C heteronuclear multiple quantum 
coherence (HMQC) experiments in DMSO-d6 solvent (fig. 8).  
Quantitative method validation 
The peak sharpness of a known sum of internal standard was equated 
to the region of the signals initiating from the drug. In this study, the 
internal standard picked was TMB; meanwhile it acquired a well-
isolated signal position with minor meddling at 2.12 ppm from analyte 
drug due to clubbed peaks in the integration areas. From, the 
commonly available internal standards, it was the excellent picked in 
sense of both chemical shifts as well the solubility. The assigned signal 
‘e’ of TMB selected in each spectra for quantification.  
For obeticholic acid, the signal at 0.602 ppm (3H) initiating from 3 
protons of the methyl groups was picked for quantification, as this 
signal appeared well-isolated by other peaks. Sample of marketed 
drug in DMSO-d6 was thoroughly mixed well and sonicated but due 
to lots of excipient it was not completely dissolved and even in other 
solvent, and lock problem also appeared during acquisition. So, the 
filtered test solution taken for acquisition of spectrum and these 
issues refrain us to not gone for further parameters evaluation. The 
1H NMR spectrum of standard drug API with TMB internal standard 
in DMSO-d6 solvent shows a well-isolated signal and especially 
desired peaks (fig. 9). 
The method was validated as stated by ICH guidelines [19] and it 
oblige all parameters; system-suitability, selectivity and specificity, 
reproducibility, accuracy, linearity, LOQ, LOD, robustness and 
stability. 
System suitability 
A system suitability scrutinize is obligatory to display that the 
control procedures have been trailed for the particular analysis at a 
given day. Such action can be applied on a method and spectrometer 
to ensure the expected trait and sensibility be reached, for instance, 
employing S/N share or line-width data in the spectrum. Due to 
great intrinsic accuracy and system precision is not mandatory for 
NMR. However, the system was performed precisely for each 
parameter via repeating the standard preparations acquisition. It 
was asked as a system suitability test, to scrutinize the agreement 
with the acceptance standards below. 
The percentage RSD of integral value of the signal should be<2.00, 
difference of δ value (in ppm) of the signal should be<0.2 ppm and S/N 
share of the signal should be>150 [16, 24]. All the three recognition 
criteria are defined in-house, as in quantification. Furthermore, an 
optional critical parameter; chemical shift must be included here, to 
identified properly, the analyte signal. Thus, system suitability results 
meet standard limitations in each validation study. 
Selectivity and specificity 
The selectivity and specificity of the offered method were assessed via 
potential interventions down to excipients in formulations. Specificity 
studies were achieved by studying the TMB internal standard, blank 
diluent (DMSO-d6), obeticholic acid standard, and marketed sample 
(tablet) preparations. It was settled that there were no interventions 
at the peaks attained at 0.602 ppm (3H) and 6.86 ppm (2H) from drug 
and TMB internal standard, respectively, just because of solvent. 
Moreover, selected signals of drug proton and TMB internal standard 
were well-isolated in sample and standard preparations (fig. 10). 
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Fig. 10: Comparison of proton nuclear magnetic resonance spectra of (a) blank deuterated dimethyl sulfoxide solvent, (b) obeticholic 
acid, (c) tetramethylbenzene internal standard and (d) sample preparation of marketed drug 
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Precision and intermediate precision 
The precision was estimated by six distinct sample preparations, the 
quantity of drug in each is calculated in % purity (Px) and statistical 
results were tabulated. The S/N share for each admeasurement must 
be ˃150:1 [16]. This study evaluated intermediate precision on 
three dissimilar occasions by preparing six distinct samples, 
analyzed on two separate probe-head namely 5 mm multinuclear 
BBO and 5 mm dual1H-13C probe by different analyst on different 
day. The average SD and RSD means from both the studies are 
documented in table 1. The overall results from precision and 
intermediate precision haven’t shown any differences. 
 
Table 1: Precision and intermediate precision test results 
Precision Intermediate precision 
Preparation Taken amount of 
drug (in mg) 
Found amount of 
drug (in mg) 
% purity (as 
such) 
Taken amount 
of drug (in mg) 
Found amount 
of drug (in mg) 




















































aMean of six determination %RSD, SD: standard deviation, RSD: relative standard deviation. 
 
Accuracy 
This parameter was evaluated from 9 determinations at 3 
concentration scales casing a specified range. It was studied at 80, 
100 and 120% scales in relation to the preparing sample solution in 
triplicate at each scale. According to the tabulated results in table 2, 
it was established that the method for assay was accurate between 
80 and 120% scales and the %RSD was found 0.6325% that is<2.00 
as stated by ICH and It is also shown in the comparative column 
chart fig. 11. 
 
Table 2: Accuracy test results obtained at 80, 100 and 120% levels with triplicate at each level 
Preparation Accuracy level (in %) Taken amount of  
drug (in mg) 





























































aMean of nine determination %RSD, SD: standard deviation, RSD: relative standard deviation, Ix: integration mean. 
 
 
Fig. 11: Comparison of accuracy result across the % range and it was found that the %RSD at each replicate level was<2%. RSD: relative 
standard deviation 
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Linearity 
Quantitative NMR method is linear in itself because the strength of 
the outcome peak is directly proportionate to the aggregate of 
contributing nuclei. This was checked by making standard solutions 
at six altered concentration scales from 70% to 120%. Its curve was 
drawn for drug amount (in mg) versus found drug amount (in mg). 
The curve equation calculated from the regression method in which 
y-axis represented found drug (in mg) and x-axis represented taken 
drug (in mg) as resultant it found that y = 0.9893x+0.087. The RSD 
and correlation coefficient (R2) was found 0.743 and 0.9989 
respectively, indicating good linearity (table 3 and fig. 12). 
 
 
Fig. 12: Linearity curve of obeticholic acid obtained by different concentration levels ranging from 70% to 120%. R2: correlation 
coefficient; y: slope-intercept 
 
Table 3: Linearity studied results acquired at different concentration levels 
Preparation Concentration 
levels (in %) 




Found amount of drug 
(in mg) 
% purity (as such) 
1. 70 7.39 0.43 7.33 99.29 
2. 80 8.27 0.49 8.36 101.2 
3. 90 9.37 0.55 9.38 100.17 
4. 100 10.27 0.60 10.23 99.70 
5. 110 11.36 0.66 11.26 99.14 
6. 120 12.46  0.73 12.45  99.98 
mean±SD 
%RSDa 
    99.91±0.7426  
0.7433 
aMean of six determination %RSD, Ix: integration mean, RSD: relative standard deviation,SD: standard deviation. 
 
Limit of detection (LOD) and quantitation (LOQ) 
In this method with Lorentzian line as respond peaks, the LOQ and LOD 
to be calculated by way of the slope (s) and the SD of the intercept (σ) of 
a calibration curve acquired in the linearity. The SD of intercept was 
calculated as 0.0231 by multiplying square-root of total number of 
preparation with standard error of intercept that is acquired as 0.0094 
by regression model in which y-axis represented integration mean and 
x-axis represented taken amount of drug. The final amount LOD and LOQ 
were studied with equation (2) and (3) respectively [23]. 
𝐿𝑂𝐷 = 3.3 𝜎 𝑠� … ….. (2) 
𝐿𝑂𝐷 = 10 𝜎 𝑠� … … ... (3) 
The calculated detection and quantitation limits were found to be 
0.0773 mg and 0.234 mg, respectively.  
Stability of solution 
The stability of the drug analyzed during the study period itself 
should not alter during the acquisition. The solution is believed to be 
stable, if percentage variance in purity is<1.0 once equated with 
initial value. In case of test solutions are not stable at ambient 
temperature, same should be recurring at refrigerated temperature 
(about 2-8 °C) [19].  
Preparation was analyzed at temperature (~25 ℃) on 0 (   
12 and 24 h pauses and calculated percent purity for every pause. 
Evaluated percent variance for preparation at altered time pause 
with regard to the initial value, as resultant no major change was 
found. Results are tabulated in table 4 and also compared the pairs 
of value with each other in fig. 13. 
 






of drug (in mg) 
Integration mean 
(Ix) 
Found amount of drug (in 
mg) 




1. Initial 10.36 0.60 10.23 98.83 NA 
2. 6 10.36 0.60 10.23 98.82 0.01 
3. 12 10.36 0.60 10.23 98.83 0.00 
4. 24 10.36 0.60 10.22 98.73 0.10 
mean±SD 
%RSDa 





aMean of four determination %RSD, Ix: integration mean, NA: not applicable, No. of readings: number of readings, RSD: relative standard deviation, 
SD: standard deviation. 
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Fig. 13: Comparison of stability of test solution at room temperature and it was noted that the % difference is less than 1% at each 
interval (per 6 h) which indicates good stability 
 
Robustness 
It is an analytical procedure that is a degree of its aptitude to stay 
untouched via little but a deliberate variant in practical parameters 
listed in the process and provides a sign of its appropriateness at 
normal practice. This method was assessed by varying 3 parameters 
individualistically:  
1) The number of scan±16 (32, 48, 64 scans), 
2) The pulse program zg and zg30, and 
3) The standard internal TMB amount variation ~20% (10±2.0 mg) 
According to the tabulated in table 5, ran the experiment by varying 
number of scan namely 32, 48, and 64 rather than 32 only didn’t 
affect the determination. A 20% variation in TMB internal standard 
quantity didn’t noticeably change the measures of drug. And by 
changing the pulse program also did not get any significant 
difference. Thereby, this study is fairly robust in terms of above 
parameters; it is also represented in comparative column charts in 
fig. 14. 
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aMean of three determination, bMean of two determination, Diff: difference, Ix: integration mean, NA: not applicable, No. of readings: number of 
readings, SD: standard deviation, zg: Pulse program of NMR. 
 
 
Fig. 14: Comparison of robustness of the method in which three parameters were changed: (a) number of scans, (b) pulse program and (c) 
amount of internal standard, and it was found that the %difference is<1% at each parameter. TMB: Tetramethylbenzene, No.: number, zg: 
Pulse program of NMR 
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Comparison with other technique 
The assay results accomplished by quantitative NMR were also 
ratified through comparison with another in-house UHPLC-MS 
tool. To assure the molecular weight and purity of the drug (1 mg 
drug sample) is solubilized in the diluent DMSO-d6. Structure 
was confirmed by observing mass spectroscopy fragment at m/z 
value 385.2 after subtracting–COOH group m/z value 45 (in 
MS+VE) and it found that standard drug was 99.85% pure with 
retention time 2.949 min which results of UHPLC-MS method 
didn’t shown any differences with quantitative NMR method as 
mentioned in fig. 15. 
 
 
Fig. 15: Liquid chromatography-mass spectrometry spectra of obeticholic acid acquired after method validation by quantitative nuclear 




The quantitative NMR method employed herein proved to be rapid 
as well as easy to implement. The different aspects of performance 
of the method, such as linearity, precision and accuracy, satisfied our 
requirements well. For initial confirmation of obeticholic acid API, 
various NMR techniques are employed for the evaluation of the drug 
as preliminary authenticity and sample assessment by several 
experiments. For the quantification of the drug obeticholic acid and 
internal reference standard TMB, the proton NMR signals at 0.602 
ppm and 6.86 ppm were used as. The curve equation calculated from 
the regression method, the RSD and correlation coefficient (R2) was 
found to be 0.743 and 0.9989 respectively, indicating good linearity. 
Assay results obtained by quantitative NMR were also confirmed by 
comparing with in-house UHPLC-MS method in which it found 
99.85%. Thus quantitative determination of drug purity was found 
to be 99.91% in linearity with LOD and LOQ values as 0.0773 mg and 
0.2344 mg respectively, making the study of method validation for 
drug obeticholic acid successful. Furthermore, modern NMRs 
operating in the field of 400MHz can be used for data processing. 
The gain of the method, that there was no standard reference of the 
drug was requisite for quantitation and its high reliability, 
simultaneously, simplicity of measurement enable it to apply for 
quantitation of obeticholic acid in commercial products. 
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al. Importance of purity evaluation and the potential of 
quantitative 1H NMR as a purity assay: miniperspective. J Med 
Chem 2014;57:9220-31. 
21. Bridwell H, Dhingra V, Peckman D, Roark J, Lehman T. 
Perspectives on method validation: importance of adequate 
method validation. Qual Assur J 2010;13:72-7. 
22. De-Souza SV, Junqueira RG. A procedure to assess linearity by 
ordinary least squares method. Anal Chimica Acta 
2005;552:25-35. 
23. Mocak J, Bond AM, Mitchell S, Scollary G. A statistical overview 
of standard (IUPAC and ACS) and new procedures for 
determining the limits of detection and quantification: 
application to voltammetric and stripping techniques 
(technical report). Pure Appl Chem 1997;69:297-328. 
24. Maniara G, Rajamoorthi K, Rajan S, Stockton GW. Method 
performance and validation for quantitative analysis by 1H and 
31P NMR spectroscopy: applications to analytical standards 
and agricultural chemicals. Anal Chem 1998;70:4921-8. 
 
